Clinical trial
A Two-Part Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of PDM608 in Healthy Adult Subjects
NCT05950906 is registered in ClinicalTrials.gov with Calibr, a division of Scripps Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Two-Part Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of PDM608 in Healthy Adult Subjects
- Lead sponsor
- Calibr, a division of Scripps Research
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 27, 2023
- Completion date
- April 19, 2024
- Enrollment
- 64 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.